Biologics - Resources

22/04/24 - Earth Day marks a moment to reflect on the planet's health and our collective efforts to nurture it. To celebrate Earth Day, this article will examine the strides the pharmaceutical and biotechnology industry has made towards fostering sustainable and green practices alongside the challenges.

Content Type

Subjects

Keywords

Vaccines

Uncovering the Latest Trends in Vaccine Development and Technology: Advances in Biotechnology and Vaccines

Vaccines

Strengthening Preparedness for the Next Pandemic: Interview with Ramin Sabet-Azad, CMC Lead, CEPI

How do we prepare for the next pandemic?

Vaccines

Vaccine Production for Better Global Access

How were the COVID-19 vaccines developed so fast? And why were some countries left behind?

Vaccines

Pioneers of COVID-19 mRNA Vaccine Win Nobel Prize

Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.

Vaccines

Personalised Cancer Vaccines: Tailored Immunotherapy for Precision Treatment

We take a look at what personalised cancer vaccines are, how they are developed, and how they are changing the field of immunotherapy.

Vaccines

How Will Commercialisation Impact COVID-19 Vaccine Prices in the US?

We take a look at how the commercialisation of COVID-19 vaccines in the US will impact the price of the vital therapeutic.

Vaccines

World Malaria Day 2023: Breakthroughs in Malaria Vaccinations

April 25th marks World Malaria Day, an opportunity to raise awareness about the disease’s impact and efforts to control and prevent it.

Vaccines

In Vivo Model Design and Assay Selection to Aid in Progression from Preclinical to Clinical

Nexelis discussed the preclinical stage of vaccine development at Vaccines EU 2022, highlighting that the choices made during this stage will impact the rest of the development process.

Vaccines

Carterra: High-Throughput SPR Technology

Vaccines

MIT Team Create AI-Generated Universal COVID Vaccine

New COVID variants are still a significant risk; but could an AI-generated universal COVID vaccine be the key to overcoming this?

Vaccines

The EMA’s Vaccines Working Party: The New Authority on Vaccines

The Vaccines Working Party was established last year by the EMA, but what are its main tasks, and how are they looking to achieve them?

Vaccines

The Race for an RSV Vaccine Approval

Things are heating up in the race to pinch the first FDA approval of an RSV vaccine, as Moderna joins Pfizer and GSK in the running.

Vaccines

Dual-Action Malaria Vaccine Takes the Punch out of the Parasite

A new vaccine duo developed by scientists at George Washington University stops malaria infection and transmission, the double attack needed to eradicate the disease.

Vaccines

Nexelis’s Collaborative Development for Optimal Clinical Assay

November’s webinar, Adaptive Laboratory Environment: Collaboration Across our Development Teams Produces Optimal Clinical Assay, discusses Nexelis’s process in recombinant protein production, optimisation, and characterisation.

Vaccines

Overcoming Vaccine Manufacturing Challenges

Experts from King’s College London, Janssen, and Merck Sharp & Dohme congregate to talk the future of optimised vaccine manufacturing.

Vaccines

Vaccines After COVID: How the Pandemic Has Changed the Vaccination Market

During the pandemic, a layperson couldn't avoid learning about vaccinations. But as the world returns to “normal”, how does this new-found focus on vaccines manifest for regulators, producers, prescribers, and the public?

Vaccines

Vaccines Europe: Presentations You Won’t Want to Miss

Find out about some of Oxford Global’s most highly anticipated presentations happening at our upcoming Vaccines Congress.

Vaccines

Universal Vaccines & Vaccine Therapeutics

Mark Doherty, Senior Medical Manager at GSK, leads a Discussion Group on leveraging the mechanisms of action in therapeutic vaccine development.

Vaccines

3-Dose Hepatitis B Vaccine Offers Full Protection for People with HIV

Phase III clinical trials from the University of Cincinnati have shown seroprotection in 100% of HIV-positive participants after a 3-dose regimen of the HEPLISAV-B vaccine.

Vaccines

Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects

Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.

Vaccines

Advanced Vaccine Platforms & Technologies

Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.

Vaccines

Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study

Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.

Vaccines

Using Humanised Mice to Evaluate Vaccine Efficacy

Kymab Ltd presents the utility of mice models for studying human immune response to complex vaccines.

Vaccines

Moderna Sues Pfizer and BioNTech over mRNA COVID-19 Vaccines

Why is Moderna suing Pfizer and BioNTech over its COVID-19 vaccine despite recent pledge?

Vaccines

mRNA Therapeutics: Learning from Preclinical Concepts to Ensure Clinical Translatability in Nanomedicinal Approaches

This Commentary article explores the applications of mRNA therapeutics in disease treatment and prevention. The commercial presence of microfluidics technologies has improved process development, and has helped to provide rapid development along with the existence of established formulation principles for vaccines.